Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids - 2Meet the astronauts about to make history on flight around the moon
- 3NMG signs new graphite supply deal with Canadian Government
- 4The Best Computer games for Multiplayer Fun
- 510 Moves toward Start Your Own Effective Business
- Vote in favor of your Number one method for commending a birthday
- Doggie diversity in size and shape began at least 11,000 years ago
- Tech giants accused of not complying with Australian social media ban
- AfD in Brandenburg takes back suit against the intelligence service
- Have gravitational waves provided the first hint of primordial black holes born during the Big Bang?
- Find the Effect of Web-based Entertainment on Psychological wellness: Exploring the Advanced Scene Securely
- Physicists and philosophers have long struggled to understand the nature of time: Here's why
- Figure out How to Involve a Brain science Certification in Showcasing
- Many European nations want Israel to cancel 19 new settlement plans
